Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jeffm34


T.TH

RE:This morning’s presentation

This afternoon's presentation  https://www.abstractsonline.com/pp8/...

April 11, 2022

T.TH

This morning’s presentation

Not sure if this abstract was posted already  https://www...

April 11, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:New PDC article mentionning TH1902 and TH1904

The way the peptide works is that you can attach different drug molecules to...

April 2, 2022

T.TH

RE:RE:RE:RE:RE:RE:New PDC article mentionning TH1902 and TH1904

https://www.liebertpub.com/doi/10.1089/dna.2017.3853 Sortilin facilitates...

April 2, 2022

T.TH

RE:RE:RE:RE:New PDC article mentionning TH1902 and TH1904

You can find articles on Sortilin and its involvement in lipid metabolism as...

April 2, 2022

T.TH

Chinese deal

Starting to look like a bit of a red herring.  A few months ago the deal...

March 22, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:New Corporate Presentation up

"Explore the need for a companion diagnostic for SORT1 to determine...

March 16, 2022

T.TH

RE:Volumes speak

One hour to go on the TSX.  7000 shares traded so far. How can...

March 15, 2022

T.TH

RE:RE:RE:RE:"first line maintenance therapy"

If Taimeds new drugs are for first line maintenance therapy, I don't...

March 3, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very difficult to be constructive

There's a lot more information we would all like to know. That doesn'...

March 2, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Very difficult to be constructive

What results are you expecting from the the phase 1a?  The only results...

March 2, 2022

T.TH

Heading lower

What is the next support level?

March 1, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Nothing changes

I don't think there was much to be positive about in the near term from...

February 28, 2022

T.TH

Year end highlights or lowlights

Cash on hand $40M More delays for the NASH program Trogarzo sales in the US...

February 24, 2022

T.TH

RE:RE:The phase 1a trial has already been de-risked

Why do you think they will see any signs of efficacy from the phase 1a trial ...

January 31, 2022

T.TH

RE:Feedback from today's Meeting with Large Shareholders

So what exactly then was the point of these meetings that could not have been...

January 24, 2022

T.TH

RE:RE:Questions during the free breakfast

Seems you might need to add: What are your thoughts on business growth and...

January 23, 2022

T.TH

RE:RE:RE:Really bizarre

This article is a pretty good indication of the lack of business leadership...

January 23, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Friday or 4pm NR is better

I think the chances of getting any efficacy results from the first part of...

January 21, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Best Case Scenario

This was from the trial coordinator at Gettysburg on January 5.  Yes...

January 19, 2022

Featured Company